Alpha Tau Medical (DRTS)
13.01
-0.31 (2.33%)
Upcoming Events
Latest Headlines
Alpha Tau reports 100% response rate in head and neck cancer combo trial
July 21, 2026 8:32 AM - StreetInsider
Form 6-K Alpha Tau Medical Ltd. For: Jul 21
July 21, 2026 8:30 AM - SEC Filing
Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic
July 21, 2026 8:30 AM - Globe NewsWire
H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS)
July 17, 2026 7:10 AM - StreetInsider
Form 6-K Alpha Tau Medical Ltd. For: Jul 15
July 15, 2026 8:30 AM - SEC Filing
Form 4 Alpha Tau Medical Ltd. For: Jul 06 Filed by: Levy Raphi
July 7, 2026 7:49 AM - SEC Filing
Form 144 Alpha Tau Medical Ltd. Filed by: Levy Raphi
July 6, 2026 11:56 AM - SEC Filing
Form 4 Alpha Tau Medical Ltd. For: Jul 02 Filed by: Levy Raphi
July 6, 2026 11:37 AM - SEC Filing
Form 4 Alpha Tau Medical Ltd. For: Jul 01 Filed by: Levy Raphi
July 2, 2026 11:46 AM - SEC Filing
Form 144 Alpha Tau Medical Ltd. Filed by: Levy Raphi
July 2, 2026 6:32 AM - SEC Filing
Form 4 Alpha Tau Medical Ltd. For: Jun 30 Filed by: Levy Raphi
July 1, 2026 8:22 AM - SEC Filing
Form 144 Alpha Tau Medical Ltd. Filed by: Levy Raphi
June 30, 2026 11:34 AM - SEC Filing
Form 4 Alpha Tau Medical Ltd. For: Jun 25 Filed by: Levy Raphi
June 26, 2026 8:18 AM - SEC Filing
Form 144 Alpha Tau Medical Ltd. Filed by: Levy Raphi
June 26, 2026 6:45 AM - SEC Filing
Form 6-K Alpha Tau Medical Ltd. For: Jun 25
June 25, 2026 4:01 PM - SEC Filing
Oramed to join Russell indexes amid $270M balance sheet
June 25, 2026 11:35 AM - StreetInsider
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
June 25, 2026 11:35 AM - PR NewsWire
Form 4 Alpha Tau Medical Ltd. For: Jun 23 Filed by: Levy Raphi
June 25, 2026 10:17 AM - SEC Filing
Form 6-K Alpha Tau Medical Ltd. For: Jun 23
June 23, 2026 4:01 PM - SEC Filing
Form 144 Alpha Tau Medical Ltd. Filed by: Levy Raphi
June 23, 2026 6:13 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS)
June 15, 2026 6:51 AM - StreetInsider
Form 6-K Alpha Tau Medical Ltd. For: Jun 11
June 11, 2026 8:36 AM - SEC Filing
Form 4 Alpha Tau Medical Ltd. For: Jun 03 Filed by: Levy Raphi
June 4, 2026 2:29 PM - SEC Filing
Form 144 Alpha Tau Medical Ltd. Filed by: Levy Raphi
June 4, 2026 7:28 AM - SEC Filing
Alpha Tau Medical Ltd. (DRTS) PT Raised to $17 at Barclays
June 4, 2026 3:54 AM - StreetInsider
Alpha Tau Medical (DRTS) 9200 contracts of June 12.50 puts trade, share price up 18.5%
June 3, 2026 3:00 PM - StreetInsider
Form 6-K Alpha Tau Medical Ltd. For: Jun 03
June 3, 2026 8:30 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS)
June 3, 2026 6:54 AM - StreetInsider
Form 6-K Alpha Tau Medical Ltd. For: Jun 01
June 1, 2026 9:00 AM - SEC Filing
Barclays Starts Alpha Tau Medical Ltd. (DRTS) at Overweight
May 28, 2026 3:36 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS)
May 20, 2026 6:47 AM - StreetInsider
Alpha Tau Medical Ltd. (DRTS) PT Raised to $8 at Piper Sandler; 'Shares are due for a breather'
May 19, 2026 7:08 AM - StreetInsider
Form 6-K Alpha Tau Medical Ltd. For: May 18
May 18, 2026 4:32 PM - SEC Filing
Alpha Tau Medical Ltd. (DRTS) Misses Q1 EPS by 14c
May 18, 2026 4:22 PM - StreetInsider
Form 6-K Alpha Tau Medical Ltd. For: May 18
May 18, 2026 4:02 PM - SEC Filing
Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 18, 2026 4:01 PM - Globe NewsWire
Alpha Tau to Participate in May Investor Conferences
May 18, 2026 8:30 AM - Globe NewsWire
Alpha Tau Medical Ltd. (DRTS) PT Raised to $14 at Ladenburg Thalmann
May 12, 2026 7:34 AM - StreetInsider
Alpha Tau Medical Ltd. (DRTS) PT Raised to $15 at H.C. Wainwright
May 12, 2026 6:50 AM - StreetInsider
Form 6-K Alpha Tau Medical Ltd. For: May 11
May 11, 2026 9:31 AM - SEC Filing
Alpha Tau reports interim brain cancer trial results in 3 patients
May 11, 2026 7:01 AM - StreetInsider
Form 6-K Alpha Tau Medical Ltd. For: May 11
May 11, 2026 7:00 AM - SEC Filing
Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Control, 67% Complete Response Rate, and Favorable Safety Profile Ob
May 11, 2026 7:00 AM - Globe NewsWire
Form 6-K Alpha Tau Medical Ltd. For: May 08
May 8, 2026 9:10 AM - SEC Filing
Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma
May 8, 2026 9:10 AM - Globe NewsWire
Alpha Tau completes enrollment in pivotal skin cancer trial
May 8, 2026 9:00 AM - StreetInsider
Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma
May 8, 2026 9:00 AM - Globe NewsWire
Form 6-K Alpha Tau Medical Ltd. For: May 08
May 8, 2026 9:00 AM - SEC Filing
Form 6-K Alpha Tau Medical Ltd. For: May 07
May 7, 2026 9:00 AM - SEC Filing
Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute
May 7, 2026 9:00 AM - Globe NewsWire
Alpha Tau to present head and neck cancer study at AHNS conference
May 5, 2026 9:15 AM - StreetInsider
Alpha Tau Announces Upcoming Podium Presentation at the AHNS 12th International Conference on Head and Neck Cancer Showcasing Study Results of Alpha DaRT® Head and Neck Cancer Combination with Pembro
May 5, 2026 9:14 AM - Globe NewsWire
Form 6-K Alpha Tau Medical Ltd. For: May 05
May 5, 2026 9:02 AM - SEC Filing
Alpha Tau reports 100% disease control in pancreatic cancer trials
May 4, 2026 9:17 AM - StreetInsider
Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026
May 4, 2026 9:17 AM - Globe NewsWire
Form 6-K Alpha Tau Medical Ltd. For: May 04
May 4, 2026 9:00 AM - SEC Filing
Form EFFECT Alpha Tau Medical Ltd.
May 4, 2026 6:06 AM - SEC Filing
Alpha Tau Medical (DRTS) files $300M mixed shelf
April 28, 2026 6:10 AM - StreetInsider
Form F-3 Alpha Tau Medical Ltd.
April 28, 2026 6:07 AM - SEC Filing
Alpha Tau abstract accepted at ASCO annual meeting for pancreatic cancer data
April 27, 2026 9:01 AM - StreetInsider
Alpha Tau Announces Presentation of Pancreatic Cancer Data at Upcoming ASCO Annual Meeting, Showcasing Combined Results from Three Alpha DaRT Pancreatic Cancer Studies
April 27, 2026 9:01 AM - Globe NewsWire
Form 6-K Alpha Tau Medical Ltd. For: Apr 27
April 27, 2026 9:00 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS)
April 27, 2026 6:49 AM - StreetInsider
Full Article List
